Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
02/06/2026
According to the disclosure from the Hong Kong Stock Exchange, BlackRock reduced its long position in H shares of China National Aviation Information Network from 12.40% to 11.72% on May 27th.
Latest
1 m ago
Puhua and Shun (01358.HK) spent HK$469,800 on June 2 to repurchase 399,000 shares.
2 m ago
Xiaocaoyuan (00999.HK) repurchased 185,600 shares on June 2nd for 1.3358 million Hong Kong dollars.
2 m ago
Analysis: The European Central Bank is expected to raise interest rates, but the weak economy has made the outlook uncertain.
2 m ago
The first dual-target CAR-T cell injection developed by the Stone Pharmaceutical Group (01093.HK) based on mRNA-LNP (SYS 6063 injection) has received clinical trial approval in China.
2 m ago
Shiyao Group (01093.HK): Phase I clinical trial data of the new B7-H3 antibody-conjugated drug SYS6043 will be presented in the form of an oral report at the 2026 ASCO Annual Meeting.
See all latest